Refractory Status Epilepticus
A 32-year-old man has had continuous generalized tonic-clonic seizures for 35 minutes. He received intravenous diazepam 10 mg twice without response. The airway is secured, oxygen saturation is 96 percent, capillary glucose is 6.1 mmol/L, and temperature is 37.1 °C. Which of the following is the most appropriate next step in management?
- A.Intravenous phenytoinCorrect
- B.Oral carbamazepine
- C.Oral ethosuximide
- D.Intramuscular midazolam
Explanation
Seizure activity persisting beyond 5 minutes is status epilepticus, and failure to respond to adequate benzodiazepine dosing defines established status epilepticus requiring an intravenous second-line antiseizure drug. Phenytoin, or preferably fosphenytoin, given as a loading dose of 20 mg/kg phenytoin equivalents, blocks voltage-gated sodium channels and terminates seizures in a substantial proportion of patients; intravenous valproate and levetiracetam are equally acceptable alternatives with comparable efficacy in the ESETT trial. The urgency reflects the fact that GABA-A receptors are internalized during prolonged seizures, so benzodiazepines lose effect while excitotoxic neuronal injury, rhabdomyolysis, hyperthermia, and acidosis accumulate. Repeating a benzodiazepine by the intramuscular route after two adequate intravenous doses simply delays effective therapy and increases respiratory depression. Oral agents are useless in a convulsing, unconscious patient who cannot swallow and in whom absorption is unpredictable. Ethosuximide is specific to absence seizures and has no role in generalized tonic-clonic status. Carbamazepine is not available intravenously and is not used acutely. If seizures continue after second-line therapy, refractory status requires intubation and anesthetic infusion with midazolam, propofol, or thiopental under continuous EEG monitoring. Reversible precipitants such as hypoglycemia, hyponatremia, drug withdrawal, and CNS infection must be sought in parallel.
Why each option
- A.
- Correct. After benzodiazepine failure, an intravenous second-line agent such as phenytoin or fosphenytoin is the next step in established status epilepticus.
- B.
- Carbamazepine has no intravenous formulation and cannot be given orally to an unconscious convulsing patient.
- C.
- Ethosuximide treats absence seizures only and is ineffective in generalized tonic-clonic status epilepticus.
- D.
- A further benzodiazepine after two adequate intravenous doses adds respiratory depression without benefit and delays definitive therapy.
Reference: Neurocritical Care Society Guideline on Status Epilepticus, updated in UpToDate 2025
This is one of 3,306 questions in the MedBoardSA SMLE bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bank